Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
1.1%
1w
2.2%
1m
3.4%
3m
1.1%
6m
13.1%
1y
2.5%
all
17.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,229 1.1%
2,015
2,320
Company Overview

Sales
13,914 Cr
Growth: 19.7%
Profit after Tax
1,779 Cr
Growth: 1.6%
Large Cap
92,025 Cr
P/E: 51.7x
Industry P/E: 27.8x
Fundamentals

Sales (Cr) ₹ 13,914
Growth 19.7%
EBITDA 24.2%
P/S 6.6x
Dividend 0.0%
P/E 51.7x
Book Value ₹ 380
PEG Ratio 2.6x
ROE 11.8%
P/B 5.8x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Followers (2)